NCT00002029View on ClinicalTrials.gov

Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Fat Emulsion 2%

DRUG

Fat Emulsion 20%

Trial Locations (2)

33126

Intracare Inc, Miami

07018

East Orange Veterans Administration Med Ctr, East Orange

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00002029 - Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent | Biotech Hunter | Biotech Hunter